Haplotype Labs develops SaaS technology to lower sequencing costs, predict and prevent diseases using polygenic risk models, and streamline processes by removing custom software pipelines.
Founded
2024
Company Stage
Pre-Seed
Investors
- Brainstorm Ventures
- Soma Capital
- Y Combinator
YC Batch
W24
Product Features & Capabilities
reduce sequencing costs by 50% - 90%, predict, detect, and prevent disease using polygenic risk models, streamline processes by eliminating bespoke software pipelines